Strategic understanding between ZEISS and QMS for diabetic retinopathy screening



Mumbai, Maharashtra, India – Business Wire India

QMS Medical Allied Services Ltd. today announced its strategic agreement with ZEISS Medical Technology India – for the screening of diabetic retinopathy. ZEISS is an internationally leading technology company operating in the optics and optoelectronics industries.

QMS Medical Allied Services (QMS-MAS) is a leading provider of knowledge-driven science solutions and promotional avenues for leading pharmaceutical manufacturers in India. With this agreement, QMS-MAS enters the field of running medical camps across sites in India.

Diabetic retinopathy (DR) is the leading cause of preventable vision loss in a third of adults over 40 with diabetes, according to a CDC survey. Diabetic retinopathy occurs when the blood vessels in the retina, at the back of the eye, change, it slowly affects a patient’s eyesight without any visible symptoms or changes in vision in the early stages. But as it progresses, it usually causes vision loss, which in many cases cannot be reversed.

Remote screening for diabetic retinopathy can help with early detection, even before there are noticeable changes in vision.

QMS-MAS will perform remote screening for diabetic retinopathy in India using the ZEISS VISUSCOUT®100 camera. “We are extremely happy to launch this unique and one-of-a-kind initiative where, in addition to remote DR screening, we will be offering various other preventive medical camps. With this initiative, we hope to make the healthcare delivery system more efficient through early detection and prompt referral of patients to improve treatment outcomes. ZEISS is an ideal partner in this step towards investing in the future of healthcare, ”said Mr. Mahesh Makhija, Managing Director of QMS Medical Allied Services Ltd.

The VISUSCOUT®100 camera is a pocket camera and imaging companion for reliably detecting and monitoring retinal disorders. Due to its light weight and compact design, it is easily movable and works great for healthcare professionals interested in a simple and cost-effective fundus imaging solution.

QMS-MAS will perform these screenings and several other tests using breakthrough point-of-care medical devices, under the banner of Unified Medicare (UMC).


Carl Zeiss Meditec AG is one of the world’s leading medical technology companies. The Company provides innovative technologies and application-oriented solutions designed to help physicians improve the quality of life for their patients. The Company offers complete solutions, including implants and consumables, to diagnose and treat eye diseases. The company creates innovative visualization solutions in the field of microsurgery. With 3,290 employees worldwide, the Group achieved sales of € 1,335.5 million in the 2019/20 financial year (as of September 30, 2020).

The Group’s headquarters are located in Jena, Germany, and it has subsidiaries in Germany and abroad. About 41 percent of the shares of Carl Zeiss Meditec AG are free float. The approx. 59% is owned by Carl Zeiss AG, one of the world’s leading groups in the optical and optoelectronic industries.

For more information, visit:

About QMS Medical Allied Services

QMS Medical Allied Services Ltd. is a leading company based in Mumbai, India, specializing in the business of scientific promotional products for pharmaceutical companies since 1994. Our motto is to bring the best scientific products, solutions and services to the pharmaceutical industry. We have a rich heritage of 27 years in the industry, creating innovative solutions to position as well as improve awareness and recall of top pharmaceutical brands. Through our strategic partnerships with companies such as 3M, Heine, BPL, Tanita, Choicemmed, KOB, we have successfully supplied breakthrough products to several large Indian and global pharmaceutical companies for their promotional campaigns.

For more information, please visit:

Media contact details

Priyanka Sharma (responsible, marketing and communications), QMS MAS,; Usharani Rajashekar (Marketing Communication), ZEISS India,



Leave A Reply